Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial

BACKGROUND: Cotrimoxazole (CTX) preventive therapy (CPT) reduces opportunistic infections and malaria in HIV-infected patients. In Africa, policies on sustained CPT during antiretroviral therapy (ART) differ between countries. We assessed the safety of discontinuing CPT in stable patients on ART in...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:PLoS One
Main Authors: Anywaine, Zacchaeus, Levin, Jonathan, Kasirye, Ronnie, Lutaakome, Joseph Kayiira, Abaasa, Andrew, Nunn, Andrew, Grosskurth, Heiner, Munderi, Paula
פורמט: Artigo
שפה:Inglês
יצא לאור: Public Library of Science 2018
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6312229/
https://ncbi.nlm.nih.gov/pubmed/30596666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0206907
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים